UPDATE: Jefferies Raises PT to $27 on Hanger Orthopedic Group; Strong Q1, WalkAide Progress

Loading...
Loading...
Jefferies increases its price target from $24.50 to $27 on Buy-rated Hanger Orthopedic Group
HGR
as the company posts strong results for its Q1. Jefferies says, "HGR's 7% same-store performance in Q1 and its progress with its WalkAide clinical trials further strengthen our positive conviction in the name. Given our view that HGR's organic growth momentum and margin expansion opportunities can drive upside vs. mgmt's guidance and current Street expectations, we believe HGR is compelling at 7x FY13 EBITDA." HGR closed at $23.29 on Wednesday.
Posted In: Analyst ColorPrice TargetReiterationPre-Market OutlookAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...